Economics & Value

Articles about real-world healthcare utilization and costs on Value-Based Cancer Care.

It is true that some branches of academic economics sometimes value theoretical insights and technical details over pragmatic results that can be broadly applied. However, most of the core insights of economic analysis tend to be accessible and have highly pragmatic implications.
Read Article



Due to changes in the US Food and Drug Administration (FDA) approval process for cancer drugs, many new cancer drugs have been approved over the past 10 to 15 years. Although the availability of these new drugs has improved survival for many cancer patients, there is increasing concern over the cost of these agents.
Read Article

Page 18 of 18